Morgan Stanley Maintains Underweight on XPLR Infr, Lowers Price Target to $10
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Robert Kad maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $11 to $10.
Morgan Stanley analyst Robert Kad maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $11 to $10.